Rifampicin の Pharmacokinetics に対する食事の影響 Effect of Meal on the Pharmacokinetics of Rifampicin

この論文にアクセスする

この論文をさがす

著者

    • 久保 博昭 KUBO Hiroaki
    • 北里大学薬学部生体分子解析学教室 Pharmaceutical Science Laboratory of Biomolecular Science, Kitasato University
    • 小池 勇一 KOIKE Yuichi
    • 奥羽大学薬学部薬物代謝・薬物治療学 Department of Drug Metabolism and Clinical Pharmacokinetics, School of Pharmaceutical Science, Ohu University

抄録

Rifampicin (RFP) is one of the first-line drugs in the treatment of tuberculosis. Worldwide, the recommended administration of RFP is before breakfast, however it is commonly administered after the meal in Japan. It is known that the absorption of RFP is affected by a meal. Therefore, the effects of meal on the pharmacokinetics of rifampicin were studied in patients with tuberculosis.<BR>Ten male patients participated in this study. Five of the ten patients were given three capsules (450mg of RFP) 30 minutes before breakfast. The other five patients were given the same dose of RFP 30 minutes after breakfast. The mean age and weight were 54.6±3.3 years and 53.9±2.7kg in the group before meal and in the after the meal group, 49.8±8.4 years and 53.8±5.0kg, respectively. All the data were expressed as mean±S.D. Blood samples were taken at 0, 2, 4 and 6 hours after capsule administration. RFP concentra tions in serum were analyzed by reversed-phase high performance liquid chromatography and the relevant pharmacokinetic parameters were calculated. Group means were compared by use of nonparametric statis tics.<BR>In the group before meal, the peak concentration (C<SUP>max</SUP>) was significantly higher than that in the group after meal (9.32±0.88μg/mL versus 5.76 ± 1.04 μg/mL, <I>p</I><0.05) and the AUC was also significantly higher than that in the group after meal (35.83±3.29μg/hr/mL versus 18.63±4.35μg/hr/mL, <I>p</I><0.05). These results suggest that RFP should be taken 30 minutes before the meal.

収録刊行物

  • 臨床薬理 = JAPANESE JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS  

    臨床薬理 = JAPANESE JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS 37(6), 353-357, 2006-11-30 

    The Japanese Society of Clinical Pharmacology and Therapeutics

参考文献:  23件

参考文献を見るにはログインが必要です。ユーザIDをお持ちでない方は新規登録してください。

各種コード

  • NII論文ID(NAID)
    10018814068
  • NII書誌ID(NCID)
    AN0025404X
  • 本文言語コード
    JPN
  • 資料種別
    SHO
  • ISSN
    03881601
  • データ提供元
    CJP書誌  J-STAGE 
ページトップへ